Latest News
New Diagnostic System Detects AATD Simultaneously in Different Countries
New Genetic Mechanism Causing AATD Revealed
Cytokine Regulation Among the Benefits of Alpha-1 Antitrypsin Therapy in AATD
New Model Provides Insights on How Hepatocytes Respond to AATD
Term Pregnancy and Successful Delivery in a Patient With AATD
Transient Elastography Useful in Identifying AATD-Related Liver Disease
AATD Treatment Benefits Neutrophil Adhesion
INBRX-101 Maintains Functional AAT Levels in Phase 1 Trial
Are C-Reactive Protein Levels Required for Diagnosing AATD?
Alvelestat Shows Effectiveness Against Lung Disease Related to AATD in Phase 2 Trial
Development of AIMers on Track for the Potential Treatment of AATD
Novel Recombinant AAT May Be Superior to Human-Derived AAT for AATD
Latest Clinical Trials
Insights
The Challenges of Using Gene Therapy to Treat Respiratory Disease
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Clinicians Weigh in on When Augmentation Therapy Is Called for in AATD
Today, experts are increasingly recognizing the positive role that ordinary physicians can play in refining diagnostic and management guidelines.
The Far-Reaching Impact of Innovative Clinical Trial Designs in Rare Disease
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Patient Perspectives
How My AlphaNet Coordinator Has Helped Me Manage AATD
My AlphaNet coordinator played a critical role in helping me accept my AATD diagnosis and the treatment steps ahead.
Being “Just” an AATD Carrier Should Not Be Taken Lightly
I am among the few in my area who was diagnosed early with alpha-1 antitrypsin deficiency (AATD), and several in my family also got tested.
How an Inhaler Can Help Patients With AATD Manage Breathing Problems
It’s a little crazy during spring for those with alpha-1 antitrypsin deficiency (AATD).
More Patient Education, Dialogue Needed on Liver Damage Risks in AATD
After reporting what might be liver pain related to alpha-1 antitrypsin deficiency (AATD), I felt more confused than ever about how to handle the situation.
Alpha-1 Features
Aytu BioPharma’s Healight Device Could Help Treat Rare Pulmonary Diseases
Aytu BioPharma has developed an endotracheal respiratory catheter which its CEO says has “tremendous potential” in IPF, PAH, and other respiratory diseases.
Inhaled Therapy Could Transform AATD Treatment Landscape
Israeli biopharma giant Kamada is banking that its inhaled AAT therapy will “revolutionize” the treatment of alpha-1 antitrypsin deficiency (AATD).
Israel Emerges as Global Powerhouse in Rare Disease Research
When it comes to rare disorders, Israel—a New Jersey-sized nation of 9.3 million that’s made headlines this year for its highly successful coronavirus vaccination campaign—is clearly an emerging powerhouse.
Emerging Therapies, COVID-19 Highlight Alpha-1 Foundation’s Upcoming ‘Virtual Education Day’
Several new treatments, including potential gene therapies, are now on the horizon for people with dangerously low levels of AAT.
Rare Care Podcast
Israeli biopharma giant Kamada is banking that its inhaled AAT therapy will “revolutionize” the treatment of alpha-1 antitrypsin deficiency (AATD).
Mark Brantly, MD, scientific director of the Alpha-1 Foundation, is the vice-chair of research in the Department of Medicine at the University of Florida in Gainesville, and has spent most of his career researching a cure for alpha-1 antitrypsin deficiency (AATD).
Alpha-1 Meeting Coverage
- Loading...
Loading...
Loading... 
Loading...